PURE BIOSCIENCE - PURE STOCK NEWS

PURE Bioscience reports financial results for the fiscal second quarter, highlighting net product sales, net loss, and business developments. Despite a decrease in sales, the company aims to expand its footprint in the food industry through brand advertising, trade shows, distributor focus, and continued innovation.

PURE Bioscience, Inc. (PURE) reported fiscal first quarter financial results, with net product sales of $718,000, a net loss of $735,000, and a net loss per share of ($0.01). The company's sales initiatives are paying off, with increased revenue and a customer-focused approach. The team is leveraging decades of combined experience and working on innovative solutions to enhance sanitation processes using IoT, SaaS, and automation.

PURE Bioscience reports financial results for fiscal year 2023, with net product sales of $1,871,000 and a net loss of ($4.0 million). Customer acceptance of SDC solutions in the food processing industry has increased, and the company has developed new applications for PURE Hard Surface. The company has attended conferences and trade shows to increase brand awareness and is working on marketing materials and website modifications. The CEO sees the increase in Q4 revenue as a turning point for the company. PURE has transitioned to an all-remote work environment since 2019.

PURE Bioscience, Inc. (OTCQB: PURE) reported its Q2 and six-month results ended January 31, 2023. Net product sales decreased to $396,000 in Q2 from $415,000 in 2022, with a net loss of $1,060,000 compared to $702,000 in the same quarter last year. For the six months, sales totaled $863,000, down from $912,000, with losses rising to $2,053,000 versus $1,498,000 year-over-year. The company appointed Robert Bartlett as the new CEO on March 15, 2023, aiming to enhance revenue and redirect sales strategies.

PURE Bioscience reported its fiscal first quarter results for the period ending October 31, 2022, with net product sales of $467,000, down from $497,000 in the previous year. The company faced a net loss of $993,000, compared to $796,000 year-over-year. Despite these challenges, substantial adoption of the SDC-based antimicrobial in potato, snack food, and bakery sectors is noted, alongside growth in the dairy industry. New regional managers have been hired to enhance sales efforts across multiple industries. CEO Tom Y. Lee highlighted positive momentum and industry acceptance.

Hydrite has secured a multi-year exclusive distribution agreement with PURE Bioscience, Inc. for its PURE® Hard Surface disinfectant in the dairy and plant-based protein markets. This SDC-based product is designed to effectively eliminate foodborne pathogens. With Hydrite's established presence in dairy processing, the partnership aims to enhance food safety and sanitation solutions. The agreement positions PURE® Hard Surface as an essential tool for dairy and plant-based protein facilities, allowing for improved sanitation practices.

PURE Bioscience reported a net product sales decrease to $1.81 million for the fiscal year ending July 31, 2022, down from $3.70 million in 2021. The net loss rose to $3.5 million, compared to $2.3 million the previous year. The company's reliance on distributors has shifted, with a newly formed in-house sales team aiming to capitalize on the janitorial and sanitation markets. Leadership expressed optimism for revenue growth in the upcoming quarters as they broaden their market reach.